{"ticker": {"uuid": "c3d0e8c7-2162-48af-a2c7-0c5923e6e706", "symbol": "RFL", "name": "Rafael Holdings, Inc.", "exchange": "NYSE", "country": "US", "sector": "Real Estate", "industry": "Real Estate Services"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Newmark (NASDAQ:NMRK) Vs The Rest Of The Consumer Discretionary - Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPOGE3NnBSeXRJc1BRY1JIWGhlSTQwMGk3alprOW5nWTl0MktJYTZFZHZJb2RuUGdrZ0tnckRTSEhmWG9kbUlzXzVvNEROSlE0ODdDTGxCcVdJQnpXdWZyVFJndDRlWjBpSDBMV1JqQnV0TWpaU3JHYnltUjdRZEx4aVlGTVppSkk4c213NW9oSWN6bkNJWnNZ?oc=5", "source_name": "Market source", "published_at": "2026-06-22T21:31:19+00:00", "published_display": "22 Jun 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Rafael Holdings Inc (RFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE9oS21ZTkZTMGtyYTdnaWtuRUFoTHF4S1Vaek5pQkpNRmRJbVNRUTl4dTBZaUJPMjIxUk02MHZTc2g4R3Ata0lwZkZCSHNPUVZ0M1psQy1LQTBqeHZYbFY1QkphZG4yazlfTTY2Z2Z5QQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:28:53+00:00", "published_display": "19 Jun 2026 02:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBGNmtBQzkxb1p2dDZXakl0LUdWTkF2Q0w4WW11eDdOME9FaUltX3ZXcHZLaXRhRTNIY0lyTGdvdnhRRzZfS1UycVhUSUpJUjR2TWVfenRoVnFPLVNqb1NsNmlDT0dqZHZmempLUXNR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T01:54:01+00:00", "published_display": "19 Jun 2026 01:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE0tNG9YYk5ObElSdE1lS1gtcVgtYVJYWjM3N0ZBWXZyeDB0NmJxaVpDU3BVWmZ0QXVCU0hIU3BGS21zVjliSGlzdnkxN2lmYllndXJSVlhDNmFpVUMtTF9UUnJBTU5ncGRuWTZ1NVZFZTZSVkpGZFNxZXlR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T00:22:27+00:00", "published_display": "19 Jun 2026 00:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9PSi03WE5NSThtZ05ILW80U19XeHFIeDkzRExpZWpueVBORVY2YlhqTnpmWVVOdmR0OVo5R2dWUzJfNnB5OGhicGVYZm9MdmFuR0Q1enQwSnVtMU5RTE5lSGpIcjVEbUMwWDlyQWtsbVZLYVlzN1Bkbw?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T00:19:51+00:00", "published_display": "19 Jun 2026 00:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBKS2xucFpMZzJCZVQ2d3dIeGRFaktfaWlOVzhCNnNXaEVEX3lPOVg0ZXVHcnUzSkR6MTg0amFLaFpiLTBEaWZkZkF2UUpGUXZVV0xhMzRfaUdGY1VLOHNHX0tpWlNjWklhejY1dWJ3cw?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T20:50:09+00:00", "published_display": "18 Jun 2026 20:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1YMkJZTUVUQ1lsb2VreHRYTU9fQ1RfZlVzMGFfSHh0THpYVUdCZlI4ZzAtcVVHS0JSS25DNEZET3l6Q3RMa1R6S2t6TE1CWm5WekJhd1JWMlY4MkkxZ19hYktUZTU5azU1Vk5PWUs2OEdIOWdxU0E?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T20:15:49+00:00", "published_display": "18 Jun 2026 20:15", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFA4Y2VtUVlzdDhNVUNZVHg5R1ZIMEE2Z3VRVHh6Q3BoTGJhYjR4LUFaTTVUdjJVNktna2NMNUFVeVlaaWRMNDRQZ09MWHNJaXIyTkxQSDlBbnRRTHNuTTBaTExieERPd0xNbVdhbnA5Yk1kMWp2WWVz?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T13:21:46+00:00", "published_display": "18 Jun 2026 13:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (RFL) CEO granted Class B shares with tax withholding update", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOZ3BWaVB3bHZ5OWQ4alZXTnhvUjVuMURFODlNcHNUdU1NeldWSzMwT1h5dS1wN25taTVFWmpNbTVNd01WbWlzaTFEa2c2emVOZUJTc3M0QV9wVXV6LUpISl9yTDdTSzk5N1Z2cnJ5U1haX3Rydk9pRGctQ1RfMjBKOU1kSnRqOW5EdUhLVnhnY2JsWWlxQ0hoUE1FYUFCRWN4bTlIMU8zYVZZa1c5amdLWVlB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T19:55:03+00:00", "published_display": "16 Jun 2026 19:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results", "summary": "Rafael Holdings, Inc. announced its financial results for the third quarter and first nine months of fiscal year 2026. The company reported a net loss of $4.2 million for the third quarter and $20.5 million for the nine months, largely due to the acquisition of Cyclo Therapeutics", "url": "https://www.manilatimes.net/2026/06/11/tmt-newswire/globenewswire/rafael-holdings-reports-third-quarter-fiscal-2026-financial-results/2363529/amp", "source_name": "The Manila Times", "published_at": "2026-06-12T09:10:25", "published_display": "12 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (NYSE: RFL) posts Q3 2026 loss as it funds Trappsol Cyclo trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPTDhQLTdUZDg0RUJPNGFkSE5iaTM0VERvTUUxUWhBcWRNMEk3bW9wbEREd1Y1ckN4WlVpbmV2SkdxTG1FNEpDY3EzM0lpNl95TGJVOWtTNUl0eE9ZekduVGhGUzB3b3hiTDVBQTlTdWJ0ZHpoY1RtU21oRTh3OFhQTG1NMEtLSGhYZGcwTlU1VjI2by1tazZFdWVtMzloaEwtYUlzVDhzOFZQa0Z3OU9LUA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T12:17:32+00:00", "published_display": "11 Jun 2026 12:17", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Rafael Holdings, Inc. Reports Material Event", "summary": "Rafael Holdings, Inc. has reported its third-quarter fiscal 2026 results, highlighting a significant clinical milestone: the completion of the last patient last visit in its pivotal Phase 3 TransportNPC\u2122 trial for Niemann-Pick Disease Type C1. The company anticipates submitting a", "url": "https://www.stocktitan.net/sec-filings/RFL/8-k-rafael-holdings-inc-reports-material-event-b1bc32e6ceae.html", "source_name": "Stock Titan", "published_at": "2026-06-11T11:41:14", "published_display": "11 Jun 2026 11:41", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rare disease trial milestone: Rafael plans 2026 NPC drug filing", "summary": "Rafael Holdings (NYSE: RFL) reported its Q3 fiscal 2026 financial results, including a net loss of $4.2 million and $30.5 million in cash. The company announced the completion of the pivotal Phase 3 TransportNPC trial and expects to submit a New Drug Application (NDA) in the seco", "url": "https://www.stocktitan.net/news/RFL/rafael-holdings-reports-third-quarter-fiscal-2026-financial-h6l8eb5r6uxq.html", "source_name": "Stock Titan", "published_at": "2026-06-11T11:41:14", "published_display": "11 Jun 2026 11:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings, Inc. Reports Q3 Fiscal 2026 Financial Results and Progress on Phase 3 TransportNPC\u2122 Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNMi01OWFiYlg0LUdiNFIwRkpXVHNyaGVsaWk2X2FuaHlGZEktUDhVR3RUMVJIakZzOUtqdTVEWGI3TEtqd1R6blVxUW1HMjA3Y2pwYXFub0E3Wk1pSlZVOGFCVndYT0ViOEFwN0pJQi0zYWV1VXZST0IxS0ZUY3hIWUtuM0FNNXdNdGNvZVJUUkdWd2VwQjJMd3RjbVZxc3lhOVZyX2lvbG5ScjBzTFJ6YVZBTS1oMThfeVppZGdBaGFSZGVQTXFBREo1UmJEWHREb3cyYUVuTHVNZnR2N041ZUFlcw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC\u2122 Study Evaluating Trappsol\u00ae Cyclo\u2122 for the Treatment of Niemann-Pick Disease Type C", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/rafael-holdings-announces-completion-last-113000912.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T11:30:00+00:00", "published_display": "10 Jun 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings completes phase 3 NPC disease trial enrollment By Investing.com", "summary": "Rafael Holdings (NYSE:RFL) has announced the completion of enrollment for its Phase 3 TransportNPC trial, evaluating Trapsol Cyclo for Niemann-Pick Disease Type C. This milestone led to a positive market response, with shares surging 43% over the past week. The company expects to", "url": "https://ca.investing.com/news/stock-market-news/rafael-holdings-completes-phase-3-npc-disease-trial-enrollment-93CH-4683987", "source_name": "Investing.com Canada", "published_at": "2026-06-10T11:39:36", "published_display": "10 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phase 3 NPC study completion positions Rafael (NYSE: RFL) for NDA filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQm40LW9wSmotX280WkhOQVc0RXQ3WUN0TEFLN09pYWc2VlpNRzB3X0tHb1FIbk9UMTZkSEVtZEhHakZTTENkZTBCeTA4WGJFYVhtcUhBVFZHWF9MWVJmOG9VR0FvYnBoLXZoN0FNZ1BXVklHTld5Z2ltOEk4WExSRG9ocmd3QndhaFhaREtpckRfdE5wV3ZUMW5CV1pBQVUzZFVXN2JCWV9ncUE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings completes phase 3 NPC disease trial enrollment", "summary": "Rafael Holdings (NYSE:RFL) has announced the completion of enrollment for its Phase 3 TransportNPC trial for Niemann-Pick Disease Type C, with the last patient finishing their 96-week visit. The company's stock surged on this news, and topline results are expected in the second h", "url": "https://www.investing.com/news/company-news/rafael-holdings-completes-phase-3-npc-disease-trial-enrollment-93CH-4734975", "source_name": "Investing.com", "published_at": "2026-06-10T07:37:00", "published_display": "10 Jun 2026 07:37", "sentiment": "positive", "sentiment_pct": 81, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Consumer Discretionary - Real Estate Services Stocks\u2019 Q1 Earnings: Opendoor (NASDAQ:OPEN) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOeWZ2M3NaT0NhcThQdXVpR0duZFBQSVdIMUt3aW1nQ1NtOUtJQXo2MTlGNXJhS0lmb1JSMnRCMTgyMjRwSjkwZndhVVdfeXJ2Q05fN3R5QzF6X3VtWjg3MGNEa2FqQXh2Ylpoa0lPSGlSZi1uc3ZGLUZtdUNfWG9aMEY3ZEdQY3BSeEhsZkVIWFFCdDl1S3hIWTE4MGxyZkxzZGhzQw?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Reflecting On Consumer Discretionary - Real Estate Services Stocks\u2019 Q1 Earnings: Offerpad (NYSE:OPAD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxNcGo1TVl1NnM4QzdPUV9UTDcyYUVtRzZuS1pNenpjSUdFYWhRcFZZOXRwSWwtUDRTMmJsbFBNUlhTS1NabEhMQWt1eU9nSlJsbzNEVFNjM3hEWmxhZjRmT2F2R0lWOHp4Q0x6aHEtRU9YYlNsNEVEdjZnRWRoOVVBSnhYQkJhV0hhWTEzX1d1dGtXNWZtNE83dFl3YjVWbFdZd3NSU0o3VVBiWTMzTnhyQnl4cmVLS1E1QUR4LVU3VXpHajZvalN1bTZJT2pCRThScDY5ZnZ5a0paN1BtZjVWaERpYldQT2ZiYjB3bFFxNmdZUU5GeUs0TFFvU3VXakFWSHZGa3VmV2tRY2M?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Rafael Holdings gains exclusive MIT Alzheimer\u2019s patent", "summary": "Rafael Holdings, through its subsidiary Cyclo Therapeutics, has secured an exclusive licensing agreement with MIT for a patent targeting ApoE4-linked Alzheimer's disease. The deal focuses on using small molecules, specifically cyclodextrins like Trappsol Cyclo, to improve brain c", "url": "https://longevity.technology/news/rafael-holdings-gains-exclusive-mit-alzheimers-patent/", "source_name": "Longevity.Technology", "published_at": "2026-04-29T02:38:53", "published_display": "29 Apr 2026 02:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Insider Ups Holding By 1,810% During Year", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/rafael-holdings-insider-ups-holding-142622929.html", "source_name": "Simply Wall St.", "published_at": "2026-04-28T14:26:22+00:00", "published_display": "28 Apr 2026 14:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Consumer Discretionary - Real Estate Services Stocks\u2019 Q4 Earnings: Howard Hughes Holdings (NYSE:HHH) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwJBVV95cUxNUE83RElkY05sN1d2SndJOGZCVFNVbXExSm9MZHpOOEFrcTc1Ym1UU3ZjSkFidnowZ1E4WVpRaWJhU2RMdEhSZXUyamxYdGh5anJJT3JTNF8wZlZvczlsTDkwdTFWYXI5Z3NoSUhoMVNxQm9aVHFCbzlja1JYTnlpc0ZTYkdmYy1QMkpheUI5OXlWV1BSSW1aSUZ3d1NJSy15V19FeGY0eTA2VVdLTEx1dDYwUnRPZTdDR0FXYWV5aHhmc19PbWUzSTlzU0daQ3NNTFhjbGlRa0gwZGxtdUZRb1dsOVdNT0dyYUpJVTBzWVhXQVM3QUZVSTZHTlJ5WHlncFphbFFPakZKTktlRHV3MmNHQ1BwTkk?oc=5", "source_name": "StockStory", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Consumer Discretionary - Real Estate Services Stocks\u2019 Q4 Earnings: RE/MAX (NYSE:RMAX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNbGt0NWpWS1ZJVko3blJOZFZMeFRGZmJrY0w4R05ROUd6Z2ZseXVaYUVJcUY1SUhPQTdaRC1lM2VWQWFKYVZEMU1aY1lVQkFmdkRTZzk3VVNjdkNmV2VWMFFMMGx6Ri1nb0dyYzhNYktWcE1RLWMtNV9WdDdqcUlWWDdZOV8tQ1hJZTFUSEFlcFdldUR6VDlNeldVV21DWHA0dWQ4bw?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Rafael Holdings Announces Patent Licensing Agreement with MIT for \u201cSmall Molecules to Improve Myelination in ApoE4 positive Alzheimer\u2019s Disease\u201d", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/rafael-holdings-announces-patent-licensing-110000887.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T11:00:00+00:00", "published_display": "22 Apr 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (NYSE: RFL) secures exclusive MIT patent license for ApoE4 Alzheimer\u2019s use", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNNnljQ2ZmM042WV9Gd2hNTkVUN0o0VVB3WDE5RVhMRFI5RnUwN3hFV1FDS0Z5X2UxTlJzdEQzc1drR0FfRnQ2ekxPeTNxekVLOFc3OE5DR1MwZ3FsSDRtTXpjUlBuSHNmaGpqRGt4ZjNSd2VFZjJ3dnpSTVJOWEhlRkpfRHVXQzB2MHdXcTJ6NjBtbDJUbk01ay1hb0RCOVhpVWVFWF9nLUFLRHM?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MIT grants Rafael exclusive rights for Alzheimer\u2019s therapy in ApoE4 patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSmZkSEhwVWJzb0owWWVFNEhyT3JDTUFWQlkyUVNWRTBJWV9QbHdmWTQ4Q3ZDRnM5YlhOUTl6STA4YUF1ZWxHWmpRZUFhRmlhUUlqdzY3c1hILTBwdlBoeFBJQnEyYkF4eE92UGNVTHRLSXJWd1NlZ2dYdGhDb1dIUjAzRmZuNFkxbXN3bWhQMjczcURvQmFDSkNGYXQ5c2VWcVVDQnBuSEVMTjVxcVplLU1XdktLX01SRUtr?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors", "summary": "Rafael Holdings, Inc. (NYSE: RFL) has announced the appointment of three biopharmaceutical leaders to its Board of Directors: Ameet Mallik, CEO of Rafael Holdings; Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc.; and Mark McCamish, M.D., Ph.D., President and CEO of Ic", "url": "https://www.quantisnow.com/insight/rafael-holdings-appoints-three-highly-experienced-biopharmaceutical-leaders-to-its-1007064", "source_name": "Quantisnow", "published_at": "2026-04-21T11:09:58", "published_display": "21 Apr 2026 11:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Consumer Discretionary - Real Estate Services Stocks Q4 Results: Benchmarking Opendoor (NASDAQ:OPEN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQd2dhTGtvaWttYm00SVVOSjVaSDNEd2Z4SnE1UGhqblMxOERhVFppWE1BRFUxdWJDY1FVZFFNSnljQm4yWTB6S09ERDY5Q0w1M2FmUUFqckFJQzQyMFRlbTJSVVJ2M0tpN0c3QUtiNjVSd3c2dk1CX2VHYmJSZmp4RzRtZE9IeHhWWTJjd2dhcDZYMnJNSWoyY1NiZFh3bWV5X0M0SE1jZXByMGZB?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Rafael Advanced Defense Systems Stock: IPO and Investment Guide", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE01SGhlTjFKSXRrcXotZFdmdk80eUlHa3lERmZ4M0xBQlF5ZGZxUml3bmlrX3BBeHpYR2pvZjZQVTQzOGQ1WkM0MG5tcWRmcVM1RGpBRzhGek1SMWlEakliX2pvclNGTDRTN1BjaTJLamxXa3M?oc=5", "source_name": "Bitget", "published_at": "2026-04-18T13:29:12+00:00", "published_display": "18 Apr 2026 13:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Third Quarter Fiscal Year 2019 Results", "summary": "Rafael Holdings, Inc. reported modest revenue of $1.4 million and a loss per share of $0.07 for the third quarter of its 2019 fiscal year. The company highlighted advancements in its pharmaceutical division, Rafael Pharma, including ongoing Phase 3 trials for CPI-613 (devimistat)", "url": "https://br.advfn.com/noticias/PRNUS/2019/artigo/80069999", "source_name": "ADVFN", "published_at": "2026-04-13T20:40:24", "published_display": "13 Apr 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Cushman & Wakefield (NYSE:CWK) In The Context Of Other Consumer Discretionary - Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQejZkUlJvckROSUlPQjBBUjVid2hyeEtNX3gyZkpRcUJYVDFrcjY2WjVfWC1aRTU4bUl4QVl2N1Frcmx2STd5TmpPQ2d3NXZJc0NQOWRWRjU1elNzVmFpMEJqUFZnRUtLZDNfd214WTdHVEl4c0Y5RDNSam9ZclBFTWlRUE13TFR1OTZmWlUyUVBIRFNGOHd0TVR1bF9sWEd6X20yakRSdw?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: eXp World (NASDAQ:EXPI) Vs The Rest Of The Consumer Discretionary - Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPa2lmZ2ZXU2hYUTYxUDRWOXh6STlZc2dyRXJYaEZDeUJLN21xN3dNRVQ0NnBxeDc2MHBMYkFJUzNlbVExcFBUVmtqVHRQZklUSU5BZGVpUzdfTjQ2YmFJOXI5UEQ2YWhEYXdyaXlhTWQ4TnFBXzJYdm5lODNFR1hwaVgyY0c5MTFPbC1uaGt6Ym5nUjh5T0lxWGotM1U1UQ?oc=5", "source_name": "Market source", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results", "summary": "Rafael Holdings (NYSE: RFL) reported its fourth quarter and full fiscal year 2022 financial results, highlighting a net loss from continuing operations of $4.6 million for Q4 and $122.8 million for the full year. The company noted it plans to use $33 million from a real estate sa", "url": "https://br.advfn.com/noticias/GLOBE/2022/artigo/89423011", "source_name": "ADVFN", "published_at": "2026-04-09T06:40:22", "published_display": "09 Apr 2026 06:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Consumer Discretionary - Real Estate Services Stocks\u2019 Q4 Earnings: Newmark (NASDAQ:NMRK) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPYkxkWFlHWmhoTW5kR1gzS1RlRVZkb201Q1VyTW5wa2JGZk9SVUQ5T2lQWGtqWjlHQnRoV21nM25wMVlyLWxHanpnUEhWdmo2VHhGMTRacE9RdGVRVDBWOWRocGtqMHRjWW80VU5UUE1tYk9qTGVfQnhuX0p2Q295Wlk3UmR3Nm93aVdtbHhWNldSMWU0amc2TmFmc293MEZlcTk0dQ?oc=5", "source_name": "Market source", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lobbying Update: $24,000 of RAFAEL HOLDINGS INC. lobbying was just disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQQnlFN0kwWHQtWkhackRSYnBla0JFRmdYcXVUQTA3Qkt2ZURfalJaWlp2dlU5aEJ5UUZtdzZfWkNUZkR6R0hqVDNXLW1ySmVKWEZzQ2ZjODA4cnJ0M3M5NlFtTXR6VEQ3S3MwWkczVl81eFlzWmhsTkc3M2NSQWN3NWhFWmgtclNPc1BHcHJoY2NQeTJ3ZjN0LVA5dkg2ajR1RVVSb2txbFFYRF9vM2VsdlhPR1UxQQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results", "summary": "Rafael Holdings, Inc. reported its financial results for the second quarter and first six months of fiscal year 2026, ending January 31, 2026. The company experienced an increased net loss primarily due to the consolidation of Cyclo Therapeutics' expenses following its acquisitio", "url": "https://www.theglobeandmail.com/investing/markets/stocks/RFL-N/pressreleases/778874/rafael-holdings-reports-second-quarter-fiscal-2026-financial-results/", "source_name": "The Globe and Mail", "published_at": "2026-03-17T10:08:55", "published_display": "17 Mar 2026 10:08", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (NYSE: RFL) posts wider Q2 loss as Phase 3 NPC1 trial advances", "summary": "Rafael Holdings (NYSE: RFL) reported a wider net loss of $6.4 million, or $0.13 per share, for Q2 fiscal 2026, compared to a $4.6 million loss a year prior, primarily due to increased R&D expenses following the acquisition of Cyclo Therapeutics. Despite the loss, the company's Ph", "url": "https://www.stocktitan.net/sec-filings/RFL/8-k-rafael-holdings-inc-reports-material-event-b6b5f402f6b2.html", "source_name": "Stock Titan", "published_at": "2026-03-17T09:39:03", "published_display": "17 Mar 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Safety board backs continued trial of Rafael drug for rare fatal disease", "summary": "Rafael Holdings (NYSE: RFL) reported a Q2 fiscal 2026 net loss of $6.4 million ($0.13/share) and $37.8 million in cash and cash equivalents. The company's Data Monitoring Committee recommended continuing the Phase 3 TransportNPC study for Trappsol Cyclo, a drug for Niemann-Pick D", "url": "https://www.stocktitan.net/news/RFL/rafael-holdings-reports-second-quarter-fiscal-2026-financial-c7ldqfdo4hes.html", "source_name": "Stock Titan", "published_at": "2026-03-16T21:10:19", "published_display": "16 Mar 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (NYSE: RFL) ramps R&D spend, widens loss on $37.8M cash balance", "summary": "Rafael Holdings (NYSE: RFL) reported a wider net loss of $16.2 million for the six months ended January 31, 2026, compared to $13.6 million in the prior year, primarily due to a significant increase in research and development expenses, which rose to $12.0 million from $2.3 milli", "url": "https://www.stocktitan.net/sec-filings/RFL/10-q-rafael-holdings-inc-quarterly-earnings-report-89adb739f5ad.html", "source_name": "Stock Titan", "published_at": "2026-03-16T20:40:49", "published_display": "16 Mar 2026 20:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CYTH Stock News Today | Earnings, Events & Price Alerts", "summary": "This article provides recent news and events related to Cyclo Therapeutics (CYTH). Key updates include its merger with Rafael Holdings, preliminary positive data from its Phase 3 TransportNPC\u2122 study for Niemann-Pick Disease Type C1, and an analyst downgrade following the merger a", "url": "https://intellectia.ai/en/stock/CYTH/news", "source_name": "Intellectia AI", "published_at": "2026-03-14T10:51:42", "published_display": "14 Mar 2026 10:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Consumer Discretionary - Real Estate Services Stocks\u2019 Q4 Earnings: CBRE (NYSE:CBRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQVk05VHQ4OVdTZGVGWG9kVGc0VWxPa0JfcXkyelczNVRwU19nWGk1UmFrbjFKY2NENEJLMkxDNE9tUl90dHQ5YWxDMGF0U2hlYjFhOHY5eWl4emxpZno0R0xmWjNoX2NxV3JoRkhVNUVFOFBfT3lhckhnUlpNbUM5YmMzVUhZNTlWX0tMaWdkQmFIZnlSLWc?oc=5", "source_name": "Market source", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "RFL SEC Filings - Rafael Holdings 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Rafael Holdings (RFL) SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports. It details the company's biotechnology focus, financial activities, corporate governance, and insider transactions. The articl", "url": "https://www.stocktitan.net/sec-filings/RFL/page-3.html", "source_name": "Stock Titan", "published_at": "2026-03-01T05:52:57", "published_display": "01 Mar 2026 05:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings, Inc. (RFL) stock price prediction 2026\u20132030", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9nUjdpTkcya3MwX2paRk9FVWpON3kwelNPYTRUYjE3eGJpdE9CemZ1U2pnX2tVRUNycUlyaFBvUTI2bWVtM1JFWWZEMG01TmpLbjlzc0piMm5Sdw?oc=5", "source_name": "Bitget", "published_at": "2026-02-12T00:58:16+00:00", "published_display": "12 Feb 2026 00:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q3 Earnings Outperformers: JLL (NYSE:JLL) And The Rest Of The Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxPU2pnSHNMWTE2SGYzUE1KcWJpd0xXYm5LOXdudDFkSmtIU1VHamJxa282NEFCUkxhR2JGOHprRzhNZ2h1NlpxSGZESmhiWWFnTy1uRmlfcEtWSjlVUHNidFN3V3o3WHo3aFVNb0dnUlJ1MU4wTGxuTlRXQldGazVDSDZTUnVTanhfWXNaNXRtUzdQZXE4RXpzTkdNNHVGLXNnNVB1YkZmQUlaOEh5YmJxLUFqT09YelJRZDhmOXNzRXNkd2xvbFl6MWU0WkpaZnNoQkdGV0VRb0draU0?oc=5", "source_name": "StockStory", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q3 Earnings Highs And Lows: Opendoor (NASDAQ:OPEN) Vs The Rest Of The Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNSlMwd2x0OXRZdS1EMUUwSWN3WE56aEdyckFQWjQ4YnNtWHJ4czZHMmtBb01wdk5XT1Q5TVJ2Wm0xMW1YRDJKY3M5Y2pQVXBOTG5mRTZZQnpOQzJlWjVCYXRnaEVSeExYTkU3QzRUN1RoSFR0dGhLWUZVZ1p2MGFILU5mUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Rafael Holdings elects directors, approves equity plan amendment at annual meeting By Investing.com", "summary": "Rafael Holdings (NYSE:RFL) held its annual meeting where shareholders elected six directors, ratified CohnReznick LLP as their independent accounting firm, and approved an amendment to the 2021 Equity Incentive Plan, increasing available Class B common stock by 1,000,000 shares. ", "url": "https://za.investing.com/news/sec-filings/rafael-holdings-elects-directors-approves-equity-plan-amendment-at-annual-meeting-93CH-4058721", "source_name": "Investing.com South Africa", "published_at": "2026-01-15T08:28:27", "published_display": "15 Jan 2026 08:28", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings elects directors, approves equity plan amendment at annual meeting", "summary": "Rafael Holdings (NYSE:RFL) held its annual meeting where shareholders elected all director nominees to one-year terms and ratified CohnReznick LLP as their independent accounting firm. Additionally, stockholders approved an amendment to the 2021 Equity Incentive Plan, increasing ", "url": "https://ng.investing.com/news/sec-filings/rafael-holdings-elects-directors-approves-equity-plan-amendment-at-annual-meeting-93CH-2285846", "source_name": "Investing.com Nigeria", "published_at": "2026-01-12T23:57:24", "published_display": "12 Jan 2026 23:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Short Interest in Rafael Holdings, Inc. (NYSE:RFL) Declines By 44.7%", "summary": "Short interest in Rafael Holdings, Inc. (NYSE:RFL) significantly decreased by 44.7% in December, bringing the total to 40,257 shares, representing about 0.1% of shares outstanding. The biotechnology and real estate company currently holds an average analyst rating of \"Sell\" follo", "url": "https://www.marketbeat.com/instant-alerts/short-interest-in-rafael-holdings-inc-nyserfl-declines-by-447-2025-12-27/", "source_name": "MarketBeat", "published_at": "2025-12-27T07:09:18", "published_display": "27 Dec 2025 07:09", "sentiment": "negative", "sentiment_pct": 28, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With Rafael Stock Sliding, Have You Assessed The Risk?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNczdTd2lfSURIMHRnb0tobjdvZ1B4UFdtQWhKeGJ2ZE03OWVxTW5mNnF4bWdpdmxIalpYZUNuakE4VHRfdS1pbnlkbTVLZU9mRVlNcUpHeGZhOUlscmxFMzFnQWZFdFdJRXBLUEszeXhob3pxQkhWbG5jemFnSW03eHFKMWd2YkdOclQwUEpGWXQ4M1ZoTm1DT3Awa2V1ZmYxUWZFdGxRRWNINUVXRDZ6TkxSbmlsRFZJTTYxeG9OQQ?oc=5", "source_name": "Trefis", "published_at": "2025-12-21T08:00:00+00:00", "published_display": "21 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results", "summary": "Rafael Holdings, Inc. reported its financial results for the first quarter of fiscal year 2026, ending October 31, 2025. The company announced a net loss of $9.8 million but expressed satisfaction with the progress of its pivotal Phase 3 TransportNPC\u2122 study for Niemann-Pick Disea", "url": "https://www.manilatimes.net/2025/12/12/tmt-newswire/globenewswire/rafael-holdings-reports-first-quarter-fiscal-2026-financial-results/2242049", "source_name": "The Manila Times", "published_at": "2025-12-16T10:08:53", "published_display": "16 Dec 2025 10:08", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings issues warrants in connection with Cyclo Therapeutics merger", "summary": "Rafael Holdings (NYSE:RFL) has issued 1,078,796 warrants, exercisable for 380,253 shares of its Class B common stock. These warrants, trading under the symbol RFL-WT on NYSE American, were issued as part of its merger with Cyclo Therapeutics. The warrants originated from outstand", "url": "https://ca.investing.com/news/sec-filings/rafael-holdings-issues-warrants-in-connection-with-cyclo-therapeutics-merger-93CH-4343938", "source_name": "Investing.com Canada", "published_at": "2025-12-06T12:09:27", "published_display": "06 Dec 2025 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Issues Warrants Post-Merger with Cyclo Therapeutics", "summary": "Rafael Holdings announced on December 2, 2025, the issuance of 1,078,796 warrants following its merger with Cyclo Therapeutics. These warrants, exercisable for 380,253 shares of Class B common stock at $14.19 per share (RFL-WT), will expire on December 11, 2025. The conversion is", "url": "https://www.tradingview.com/news/tradingview:4feab364ea4a2:0-rafael-holdings-issues-warrants-post-merger-with-cyclo-therapeutics/", "source_name": "TradingView", "published_at": "2025-12-03T04:31:15", "published_display": "03 Dec 2025 04:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results", "summary": "Rafael Holdings (NYSE: RFL) has released its financial results for the fourth quarter and full fiscal year ended July 31, 2025. The company highlighted the continued progress of its Phase 3 TransportNPC\u2122 study for Niemann-Pick Disease Type C1 and its enhanced financial position f", "url": "https://www.manilatimes.net/2025/10/30/tmt-newswire/globenewswire/rafael-holdings-reports-fourth-quarter-and-full-year-fiscal-2025-financial-results/2211608", "source_name": "The Manila Times", "published_at": "2025-11-14T12:08:29", "published_display": "14 Nov 2025 12:08", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings, Inc. Reports Continued Progress in Phase 3 Trial of Trappsol\u00ae Cyclo\u2122 for Niemann-Pick Disease Type C1 and Announces New COO", "summary": "Rafael Holdings, Inc. announced continued progress in its Phase 3 clinical trial of Trappsol\u00ae Cyclo\u2122 for Niemann-Pick Disease Type C1, with the Data Monitoring Committee recommending its continuation. The company also reported its fourth-quarter and full fiscal year 2025 financia", "url": "https://www.quiverquant.com/news/Rafael+Holdings%2C+Inc.+Reports+Continued+Progress+in+Phase+3+Trial+of+Trappsol%C2%AE+Cyclo%E2%84%A2+for+Niemann-Pick+Disease+Type+C1+and+Announces+New+COO", "source_name": "Quiver Quantitative", "published_at": "2025-10-29T20:34:00", "published_display": "29 Oct 2025 20:34", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Rafael Holdings Inc (RFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE9oS21ZTkZTMGtyYTdnaWtuRUFoTHF4S1Vaek5pQkpNRmRJbVNRUTl4dTBZaUJPMjIxUk02MHZTc2g4R3Ata0lwZkZCSHNPUVZ0M1psQy1LQTBqeHZYbFY1QkphZG4yazlfTTY2Z2Z5QQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:28:53+00:00", "published_display": "19 Jun 2026 02:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBGNmtBQzkxb1p2dDZXakl0LUdWTkF2Q0w4WW11eDdOME9FaUltX3ZXcHZLaXRhRTNIY0lyTGdvdnhRRzZfS1UycVhUSUpJUjR2TWVfenRoVnFPLVNqb1NsNmlDT0dqZHZmempLUXNR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T01:54:01+00:00", "published_display": "19 Jun 2026 01:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE0tNG9YYk5ObElSdE1lS1gtcVgtYVJYWjM3N0ZBWXZyeDB0NmJxaVpDU3BVWmZ0QXVCU0hIU3BGS21zVjliSGlzdnkxN2lmYllndXJSVlhDNmFpVUMtTF9UUnJBTU5ncGRuWTZ1NVZFZTZSVkpGZFNxZXlR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T00:22:27+00:00", "published_display": "19 Jun 2026 00:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9PSi03WE5NSThtZ05ILW80U19XeHFIeDkzRExpZWpueVBORVY2YlhqTnpmWVVOdmR0OVo5R2dWUzJfNnB5OGhicGVYZm9MdmFuR0Q1enQwSnVtMU5RTE5lSGpIcjVEbUMwWDlyQWtsbVZLYVlzN1Bkbw?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T00:19:51+00:00", "published_display": "19 Jun 2026 00:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBKS2xucFpMZzJCZVQ2d3dIeGRFaktfaWlOVzhCNnNXaEVEX3lPOVg0ZXVHcnUzSkR6MTg0amFLaFpiLTBEaWZkZkF2UUpGUXZVV0xhMzRfaUdGY1VLOHNHX0tpWlNjWklhejY1dWJ3cw?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T20:50:09+00:00", "published_display": "18 Jun 2026 20:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1YMkJZTUVUQ1lsb2VreHRYTU9fQ1RfZlVzMGFfSHh0THpYVUdCZlI4ZzAtcVVHS0JSS25DNEZET3l6Q3RMa1R6S2t6TE1CWm5WekJhd1JWMlY4MkkxZ19hYktUZTU5azU1Vk5PWUs2OEdIOWdxU0E?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T20:15:49+00:00", "published_display": "18 Jun 2026 20:15", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Inc (RFL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFA4Y2VtUVlzdDhNVUNZVHg5R1ZIMEE2Z3VRVHh6Q3BoTGJhYjR4LUFaTTVUdjJVNktna2NMNUFVeVlaaWRMNDRQZ09MWHNJaXIyTkxQSDlBbnRRTHNuTTBaTExieERPd0xNbVdhbnA5Yk1kMWp2WWVz?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T13:21:46+00:00", "published_display": "18 Jun 2026 13:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (RFL) CEO granted Class B shares with tax withholding update", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOZ3BWaVB3bHZ5OWQ4alZXTnhvUjVuMURFODlNcHNUdU1NeldWSzMwT1h5dS1wN25taTVFWmpNbTVNd01WbWlzaTFEa2c2emVOZUJTc3M0QV9wVXV6LUpISl9yTDdTSzk5N1Z2cnJ5U1haX3Rydk9pRGctQ1RfMjBKOU1kSnRqOW5EdUhLVnhnY2JsWWlxQ0hoUE1FYUFCRWN4bTlIMU8zYVZZa1c5amdLWVlB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T19:55:03+00:00", "published_display": "16 Jun 2026 19:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results", "summary": "Rafael Holdings, Inc. announced its financial results for the third quarter and first nine months of fiscal year 2026. The company reported a net loss of $4.2 million for the third quarter and $20.5 million for the nine months, largely due to the acquisition of Cyclo Therapeutics", "url": "https://www.manilatimes.net/2026/06/11/tmt-newswire/globenewswire/rafael-holdings-reports-third-quarter-fiscal-2026-financial-results/2363529/amp", "source_name": "The Manila Times", "published_at": "2026-06-12T09:10:25", "published_display": "12 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (NYSE: RFL) posts Q3 2026 loss as it funds Trappsol Cyclo trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPTDhQLTdUZDg0RUJPNGFkSE5iaTM0VERvTUUxUWhBcWRNMEk3bW9wbEREd1Y1ckN4WlVpbmV2SkdxTG1FNEpDY3EzM0lpNl95TGJVOWtTNUl0eE9ZekduVGhGUzB3b3hiTDVBQTlTdWJ0ZHpoY1RtU21oRTh3OFhQTG1NMEtLSGhYZGcwTlU1VjI2by1tazZFdWVtMzloaEwtYUlzVDhzOFZQa0Z3OU9LUA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T12:17:32+00:00", "published_display": "11 Jun 2026 12:17", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Rafael Holdings, Inc. Reports Material Event", "summary": "Rafael Holdings, Inc. has reported its third-quarter fiscal 2026 results, highlighting a significant clinical milestone: the completion of the last patient last visit in its pivotal Phase 3 TransportNPC\u2122 trial for Niemann-Pick Disease Type C1. The company anticipates submitting a", "url": "https://www.stocktitan.net/sec-filings/RFL/8-k-rafael-holdings-inc-reports-material-event-b1bc32e6ceae.html", "source_name": "Stock Titan", "published_at": "2026-06-11T11:41:14", "published_display": "11 Jun 2026 11:41", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rare disease trial milestone: Rafael plans 2026 NPC drug filing", "summary": "Rafael Holdings (NYSE: RFL) reported its Q3 fiscal 2026 financial results, including a net loss of $4.2 million and $30.5 million in cash. The company announced the completion of the pivotal Phase 3 TransportNPC trial and expects to submit a New Drug Application (NDA) in the seco", "url": "https://www.stocktitan.net/news/RFL/rafael-holdings-reports-third-quarter-fiscal-2026-financial-h6l8eb5r6uxq.html", "source_name": "Stock Titan", "published_at": "2026-06-11T11:41:14", "published_display": "11 Jun 2026 11:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings, Inc. Reports Q3 Fiscal 2026 Financial Results and Progress on Phase 3 TransportNPC\u2122 Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNMi01OWFiYlg0LUdiNFIwRkpXVHNyaGVsaWk2X2FuaHlGZEktUDhVR3RUMVJIakZzOUtqdTVEWGI3TEtqd1R6blVxUW1HMjA3Y2pwYXFub0E3Wk1pSlZVOGFCVndYT0ViOEFwN0pJQi0zYWV1VXZST0IxS0ZUY3hIWUtuM0FNNXdNdGNvZVJUUkdWd2VwQjJMd3RjbVZxc3lhOVZyX2lvbG5ScjBzTFJ6YVZBTS1oMThfeVppZGdBaGFSZGVQTXFBREo1UmJEWHREb3cyYUVuTHVNZnR2N041ZUFlcw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC\u2122 Study Evaluating Trappsol\u00ae Cyclo\u2122 for the Treatment of Niemann-Pick Disease Type C", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/rafael-holdings-announces-completion-last-113000912.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T11:30:00+00:00", "published_display": "10 Jun 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings completes phase 3 NPC disease trial enrollment By Investing.com", "summary": "Rafael Holdings (NYSE:RFL) has announced the completion of enrollment for its Phase 3 TransportNPC trial, evaluating Trapsol Cyclo for Niemann-Pick Disease Type C. This milestone led to a positive market response, with shares surging 43% over the past week. The company expects to", "url": "https://ca.investing.com/news/stock-market-news/rafael-holdings-completes-phase-3-npc-disease-trial-enrollment-93CH-4683987", "source_name": "Investing.com Canada", "published_at": "2026-06-10T11:39:36", "published_display": "10 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phase 3 NPC study completion positions Rafael (NYSE: RFL) for NDA filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQm40LW9wSmotX280WkhOQVc0RXQ3WUN0TEFLN09pYWc2VlpNRzB3X0tHb1FIbk9UMTZkSEVtZEhHakZTTENkZTBCeTA4WGJFYVhtcUhBVFZHWF9MWVJmOG9VR0FvYnBoLXZoN0FNZ1BXVklHTld5Z2ltOEk4WExSRG9ocmd3QndhaFhaREtpckRfdE5wV3ZUMW5CV1pBQVUzZFVXN2JCWV9ncUE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings completes phase 3 NPC disease trial enrollment", "summary": "Rafael Holdings (NYSE:RFL) has announced the completion of enrollment for its Phase 3 TransportNPC trial for Niemann-Pick Disease Type C, with the last patient finishing their 96-week visit. The company's stock surged on this news, and topline results are expected in the second h", "url": "https://www.investing.com/news/company-news/rafael-holdings-completes-phase-3-npc-disease-trial-enrollment-93CH-4734975", "source_name": "Investing.com", "published_at": "2026-06-10T07:37:00", "published_display": "10 Jun 2026 07:37", "sentiment": "positive", "sentiment_pct": 81, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings gains exclusive MIT Alzheimer\u2019s patent", "summary": "Rafael Holdings, through its subsidiary Cyclo Therapeutics, has secured an exclusive licensing agreement with MIT for a patent targeting ApoE4-linked Alzheimer's disease. The deal focuses on using small molecules, specifically cyclodextrins like Trappsol Cyclo, to improve brain c", "url": "https://longevity.technology/news/rafael-holdings-gains-exclusive-mit-alzheimers-patent/", "source_name": "Longevity.Technology", "published_at": "2026-04-29T02:38:53", "published_display": "29 Apr 2026 02:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Insider Ups Holding By 1,810% During Year", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/rafael-holdings-insider-ups-holding-142622929.html", "source_name": "Simply Wall St.", "published_at": "2026-04-28T14:26:22+00:00", "published_display": "28 Apr 2026 14:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Announces Patent Licensing Agreement with MIT for \u201cSmall Molecules to Improve Myelination in ApoE4 positive Alzheimer\u2019s Disease\u201d", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/rafael-holdings-announces-patent-licensing-110000887.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T11:00:00+00:00", "published_display": "22 Apr 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (NYSE: RFL) secures exclusive MIT patent license for ApoE4 Alzheimer\u2019s use", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNNnljQ2ZmM042WV9Gd2hNTkVUN0o0VVB3WDE5RVhMRFI5RnUwN3hFV1FDS0Z5X2UxTlJzdEQzc1drR0FfRnQ2ekxPeTNxekVLOFc3OE5DR1MwZ3FsSDRtTXpjUlBuSHNmaGpqRGt4ZjNSd2VFZjJ3dnpSTVJOWEhlRkpfRHVXQzB2MHdXcTJ6NjBtbDJUbk01ay1hb0RCOVhpVWVFWF9nLUFLRHM?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MIT grants Rafael exclusive rights for Alzheimer\u2019s therapy in ApoE4 patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSmZkSEhwVWJzb0owWWVFNEhyT3JDTUFWQlkyUVNWRTBJWV9QbHdmWTQ4Q3ZDRnM5YlhOUTl6STA4YUF1ZWxHWmpRZUFhRmlhUUlqdzY3c1hILTBwdlBoeFBJQnEyYkF4eE92UGNVTHRLSXJWd1NlZ2dYdGhDb1dIUjAzRmZuNFkxbXN3bWhQMjczcURvQmFDSkNGYXQ5c2VWcVVDQnBuSEVMTjVxcVplLU1XdktLX01SRUtr?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors", "summary": "Rafael Holdings, Inc. (NYSE: RFL) has announced the appointment of three biopharmaceutical leaders to its Board of Directors: Ameet Mallik, CEO of Rafael Holdings; Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc.; and Mark McCamish, M.D., Ph.D., President and CEO of Ic", "url": "https://www.quantisnow.com/insight/rafael-holdings-appoints-three-highly-experienced-biopharmaceutical-leaders-to-its-1007064", "source_name": "Quantisnow", "published_at": "2026-04-21T11:09:58", "published_display": "21 Apr 2026 11:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Advanced Defense Systems Stock: IPO and Investment Guide", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE01SGhlTjFKSXRrcXotZFdmdk80eUlHa3lERmZ4M0xBQlF5ZGZxUml3bmlrX3BBeHpYR2pvZjZQVTQzOGQ1WkM0MG5tcWRmcVM1RGpBRzhGek1SMWlEakliX2pvclNGTDRTN1BjaTJLamxXa3M?oc=5", "source_name": "Bitget", "published_at": "2026-04-18T13:29:12+00:00", "published_display": "18 Apr 2026 13:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Third Quarter Fiscal Year 2019 Results", "summary": "Rafael Holdings, Inc. reported modest revenue of $1.4 million and a loss per share of $0.07 for the third quarter of its 2019 fiscal year. The company highlighted advancements in its pharmaceutical division, Rafael Pharma, including ongoing Phase 3 trials for CPI-613 (devimistat)", "url": "https://br.advfn.com/noticias/PRNUS/2019/artigo/80069999", "source_name": "ADVFN", "published_at": "2026-04-13T20:40:24", "published_display": "13 Apr 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results", "summary": "Rafael Holdings (NYSE: RFL) reported its fourth quarter and full fiscal year 2022 financial results, highlighting a net loss from continuing operations of $4.6 million for Q4 and $122.8 million for the full year. The company noted it plans to use $33 million from a real estate sa", "url": "https://br.advfn.com/noticias/GLOBE/2022/artigo/89423011", "source_name": "ADVFN", "published_at": "2026-04-09T06:40:22", "published_display": "09 Apr 2026 06:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lobbying Update: $24,000 of RAFAEL HOLDINGS INC. lobbying was just disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQQnlFN0kwWHQtWkhackRSYnBla0JFRmdYcXVUQTA3Qkt2ZURfalJaWlp2dlU5aEJ5UUZtdzZfWkNUZkR6R0hqVDNXLW1ySmVKWEZzQ2ZjODA4cnJ0M3M5NlFtTXR6VEQ3S3MwWkczVl81eFlzWmhsTkc3M2NSQWN3NWhFWmgtclNPc1BHcHJoY2NQeTJ3ZjN0LVA5dkg2ajR1RVVSb2txbFFYRF9vM2VsdlhPR1UxQQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results", "summary": "Rafael Holdings, Inc. reported its financial results for the second quarter and first six months of fiscal year 2026, ending January 31, 2026. The company experienced an increased net loss primarily due to the consolidation of Cyclo Therapeutics' expenses following its acquisitio", "url": "https://www.theglobeandmail.com/investing/markets/stocks/RFL-N/pressreleases/778874/rafael-holdings-reports-second-quarter-fiscal-2026-financial-results/", "source_name": "The Globe and Mail", "published_at": "2026-03-17T10:08:55", "published_display": "17 Mar 2026 10:08", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (NYSE: RFL) posts wider Q2 loss as Phase 3 NPC1 trial advances", "summary": "Rafael Holdings (NYSE: RFL) reported a wider net loss of $6.4 million, or $0.13 per share, for Q2 fiscal 2026, compared to a $4.6 million loss a year prior, primarily due to increased R&D expenses following the acquisition of Cyclo Therapeutics. Despite the loss, the company's Ph", "url": "https://www.stocktitan.net/sec-filings/RFL/8-k-rafael-holdings-inc-reports-material-event-b6b5f402f6b2.html", "source_name": "Stock Titan", "published_at": "2026-03-17T09:39:03", "published_display": "17 Mar 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Safety board backs continued trial of Rafael drug for rare fatal disease", "summary": "Rafael Holdings (NYSE: RFL) reported a Q2 fiscal 2026 net loss of $6.4 million ($0.13/share) and $37.8 million in cash and cash equivalents. The company's Data Monitoring Committee recommended continuing the Phase 3 TransportNPC study for Trappsol Cyclo, a drug for Niemann-Pick D", "url": "https://www.stocktitan.net/news/RFL/rafael-holdings-reports-second-quarter-fiscal-2026-financial-c7ldqfdo4hes.html", "source_name": "Stock Titan", "published_at": "2026-03-16T21:10:19", "published_display": "16 Mar 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings (NYSE: RFL) ramps R&D spend, widens loss on $37.8M cash balance", "summary": "Rafael Holdings (NYSE: RFL) reported a wider net loss of $16.2 million for the six months ended January 31, 2026, compared to $13.6 million in the prior year, primarily due to a significant increase in research and development expenses, which rose to $12.0 million from $2.3 milli", "url": "https://www.stocktitan.net/sec-filings/RFL/10-q-rafael-holdings-inc-quarterly-earnings-report-89adb739f5ad.html", "source_name": "Stock Titan", "published_at": "2026-03-16T20:40:49", "published_display": "16 Mar 2026 20:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CYTH Stock News Today | Earnings, Events & Price Alerts", "summary": "This article provides recent news and events related to Cyclo Therapeutics (CYTH). Key updates include its merger with Rafael Holdings, preliminary positive data from its Phase 3 TransportNPC\u2122 study for Niemann-Pick Disease Type C1, and an analyst downgrade following the merger a", "url": "https://intellectia.ai/en/stock/CYTH/news", "source_name": "Intellectia AI", "published_at": "2026-03-14T10:51:42", "published_display": "14 Mar 2026 10:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RFL SEC Filings - Rafael Holdings 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Rafael Holdings (RFL) SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports. It details the company's biotechnology focus, financial activities, corporate governance, and insider transactions. The articl", "url": "https://www.stocktitan.net/sec-filings/RFL/page-3.html", "source_name": "Stock Titan", "published_at": "2026-03-01T05:52:57", "published_display": "01 Mar 2026 05:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings, Inc. (RFL) stock price prediction 2026\u20132030", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9nUjdpTkcya3MwX2paRk9FVWpON3kwelNPYTRUYjE3eGJpdE9CemZ1U2pnX2tVRUNycUlyaFBvUTI2bWVtM1JFWWZEMG01TmpLbjlzc0piMm5Sdw?oc=5", "source_name": "Bitget", "published_at": "2026-02-12T00:58:16+00:00", "published_display": "12 Feb 2026 00:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings elects directors, approves equity plan amendment at annual meeting By Investing.com", "summary": "Rafael Holdings (NYSE:RFL) held its annual meeting where shareholders elected six directors, ratified CohnReznick LLP as their independent accounting firm, and approved an amendment to the 2021 Equity Incentive Plan, increasing available Class B common stock by 1,000,000 shares. ", "url": "https://za.investing.com/news/sec-filings/rafael-holdings-elects-directors-approves-equity-plan-amendment-at-annual-meeting-93CH-4058721", "source_name": "Investing.com South Africa", "published_at": "2026-01-15T08:28:27", "published_display": "15 Jan 2026 08:28", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings elects directors, approves equity plan amendment at annual meeting", "summary": "Rafael Holdings (NYSE:RFL) held its annual meeting where shareholders elected all director nominees to one-year terms and ratified CohnReznick LLP as their independent accounting firm. Additionally, stockholders approved an amendment to the 2021 Equity Incentive Plan, increasing ", "url": "https://ng.investing.com/news/sec-filings/rafael-holdings-elects-directors-approves-equity-plan-amendment-at-annual-meeting-93CH-2285846", "source_name": "Investing.com Nigeria", "published_at": "2026-01-12T23:57:24", "published_display": "12 Jan 2026 23:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Short Interest in Rafael Holdings, Inc. (NYSE:RFL) Declines By 44.7%", "summary": "Short interest in Rafael Holdings, Inc. (NYSE:RFL) significantly decreased by 44.7% in December, bringing the total to 40,257 shares, representing about 0.1% of shares outstanding. The biotechnology and real estate company currently holds an average analyst rating of \"Sell\" follo", "url": "https://www.marketbeat.com/instant-alerts/short-interest-in-rafael-holdings-inc-nyserfl-declines-by-447-2025-12-27/", "source_name": "MarketBeat", "published_at": "2025-12-27T07:09:18", "published_display": "27 Dec 2025 07:09", "sentiment": "negative", "sentiment_pct": 28, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With Rafael Stock Sliding, Have You Assessed The Risk?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNczdTd2lfSURIMHRnb0tobjdvZ1B4UFdtQWhKeGJ2ZE03OWVxTW5mNnF4bWdpdmxIalpYZUNuakE4VHRfdS1pbnlkbTVLZU9mRVlNcUpHeGZhOUlscmxFMzFnQWZFdFdJRXBLUEszeXhob3pxQkhWbG5jemFnSW03eHFKMWd2YkdOclQwUEpGWXQ4M1ZoTm1DT3Awa2V1ZmYxUWZFdGxRRWNINUVXRDZ6TkxSbmlsRFZJTTYxeG9OQQ?oc=5", "source_name": "Trefis", "published_at": "2025-12-21T08:00:00+00:00", "published_display": "21 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results", "summary": "Rafael Holdings, Inc. reported its financial results for the first quarter of fiscal year 2026, ending October 31, 2025. The company announced a net loss of $9.8 million but expressed satisfaction with the progress of its pivotal Phase 3 TransportNPC\u2122 study for Niemann-Pick Disea", "url": "https://www.manilatimes.net/2025/12/12/tmt-newswire/globenewswire/rafael-holdings-reports-first-quarter-fiscal-2026-financial-results/2242049", "source_name": "The Manila Times", "published_at": "2025-12-16T10:08:53", "published_display": "16 Dec 2025 10:08", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings issues warrants in connection with Cyclo Therapeutics merger", "summary": "Rafael Holdings (NYSE:RFL) has issued 1,078,796 warrants, exercisable for 380,253 shares of its Class B common stock. These warrants, trading under the symbol RFL-WT on NYSE American, were issued as part of its merger with Cyclo Therapeutics. The warrants originated from outstand", "url": "https://ca.investing.com/news/sec-filings/rafael-holdings-issues-warrants-in-connection-with-cyclo-therapeutics-merger-93CH-4343938", "source_name": "Investing.com Canada", "published_at": "2025-12-06T12:09:27", "published_display": "06 Dec 2025 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Issues Warrants Post-Merger with Cyclo Therapeutics", "summary": "Rafael Holdings announced on December 2, 2025, the issuance of 1,078,796 warrants following its merger with Cyclo Therapeutics. These warrants, exercisable for 380,253 shares of Class B common stock at $14.19 per share (RFL-WT), will expire on December 11, 2025. The conversion is", "url": "https://www.tradingview.com/news/tradingview:4feab364ea4a2:0-rafael-holdings-issues-warrants-post-merger-with-cyclo-therapeutics/", "source_name": "TradingView", "published_at": "2025-12-03T04:31:15", "published_display": "03 Dec 2025 04:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results", "summary": "Rafael Holdings (NYSE: RFL) has released its financial results for the fourth quarter and full fiscal year ended July 31, 2025. The company highlighted the continued progress of its Phase 3 TransportNPC\u2122 study for Niemann-Pick Disease Type C1 and its enhanced financial position f", "url": "https://www.manilatimes.net/2025/10/30/tmt-newswire/globenewswire/rafael-holdings-reports-fourth-quarter-and-full-year-fiscal-2025-financial-results/2211608", "source_name": "The Manila Times", "published_at": "2025-11-14T12:08:29", "published_display": "14 Nov 2025 12:08", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rafael Holdings, Inc. Reports Continued Progress in Phase 3 Trial of Trappsol\u00ae Cyclo\u2122 for Niemann-Pick Disease Type C1 and Announces New COO", "summary": "Rafael Holdings, Inc. announced continued progress in its Phase 3 clinical trial of Trappsol\u00ae Cyclo\u2122 for Niemann-Pick Disease Type C1, with the Data Monitoring Committee recommending its continuation. The company also reported its fourth-quarter and full fiscal year 2025 financia", "url": "https://www.quiverquant.com/news/Rafael+Holdings%2C+Inc.+Reports+Continued+Progress+in+Phase+3+Trial+of+Trappsol%C2%AE+Cyclo%E2%84%A2+for+Niemann-Pick+Disease+Type+C1+and+Announces+New+COO", "source_name": "Quiver Quantitative", "published_at": "2025-10-29T20:34:00", "published_display": "29 Oct 2025 20:34", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Newmark (NASDAQ:NMRK) Vs The Rest Of The Consumer Discretionary - Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPOGE3NnBSeXRJc1BRY1JIWGhlSTQwMGk3alprOW5nWTl0MktJYTZFZHZJb2RuUGdrZ0tnckRTSEhmWG9kbUlzXzVvNEROSlE0ODdDTGxCcVdJQnpXdWZyVFJndDRlWjBpSDBMV1JqQnV0TWpaU3JHYnltUjdRZEx4aVlGTVppSkk4c213NW9oSWN6bkNJWnNZ?oc=5", "source_name": "Market source", "published_at": "2026-06-22T21:31:19+00:00", "published_display": "22 Jun 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Consumer Discretionary - Real Estate Services Stocks\u2019 Q1 Earnings: Opendoor (NASDAQ:OPEN) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOeWZ2M3NaT0NhcThQdXVpR0duZFBQSVdIMUt3aW1nQ1NtOUtJQXo2MTlGNXJhS0lmb1JSMnRCMTgyMjRwSjkwZndhVVdfeXJ2Q05fN3R5QzF6X3VtWjg3MGNEa2FqQXh2Ylpoa0lPSGlSZi1uc3ZGLUZtdUNfWG9aMEY3ZEdQY3BSeEhsZkVIWFFCdDl1S3hIWTE4MGxyZkxzZGhzQw?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Reflecting On Consumer Discretionary - Real Estate Services Stocks\u2019 Q1 Earnings: Offerpad (NYSE:OPAD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxNcGo1TVl1NnM4QzdPUV9UTDcyYUVtRzZuS1pNenpjSUdFYWhRcFZZOXRwSWwtUDRTMmJsbFBNUlhTS1NabEhMQWt1eU9nSlJsbzNEVFNjM3hEWmxhZjRmT2F2R0lWOHp4Q0x6aHEtRU9YYlNsNEVEdjZnRWRoOVVBSnhYQkJhV0hhWTEzX1d1dGtXNWZtNE83dFl3YjVWbFdZd3NSU0o3VVBiWTMzTnhyQnl4cmVLS1E1QUR4LVU3VXpHajZvalN1bTZJT2pCRThScDY5ZnZ5a0paN1BtZjVWaERpYldQT2ZiYjB3bFFxNmdZUU5GeUs0TFFvU3VXakFWSHZGa3VmV2tRY2M?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Consumer Discretionary - Real Estate Services Stocks\u2019 Q4 Earnings: Howard Hughes Holdings (NYSE:HHH) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwJBVV95cUxNUE83RElkY05sN1d2SndJOGZCVFNVbXExSm9MZHpOOEFrcTc1Ym1UU3ZjSkFidnowZ1E4WVpRaWJhU2RMdEhSZXUyamxYdGh5anJJT3JTNF8wZlZvczlsTDkwdTFWYXI5Z3NoSUhoMVNxQm9aVHFCbzlja1JYTnlpc0ZTYkdmYy1QMkpheUI5OXlWV1BSSW1aSUZ3d1NJSy15V19FeGY0eTA2VVdLTEx1dDYwUnRPZTdDR0FXYWV5aHhmc19PbWUzSTlzU0daQ3NNTFhjbGlRa0gwZGxtdUZRb1dsOVdNT0dyYUpJVTBzWVhXQVM3QUZVSTZHTlJ5WHlncFphbFFPakZKTktlRHV3MmNHQ1BwTkk?oc=5", "source_name": "StockStory", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Consumer Discretionary - Real Estate Services Stocks\u2019 Q4 Earnings: RE/MAX (NYSE:RMAX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNbGt0NWpWS1ZJVko3blJOZFZMeFRGZmJrY0w4R05ROUd6Z2ZseXVaYUVJcUY1SUhPQTdaRC1lM2VWQWFKYVZEMU1aY1lVQkFmdkRTZzk3VVNjdkNmV2VWMFFMMGx6Ri1nb0dyYzhNYktWcE1RLWMtNV9WdDdqcUlWWDdZOV8tQ1hJZTFUSEFlcFdldUR6VDlNeldVV21DWHA0dWQ4bw?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Consumer Discretionary - Real Estate Services Stocks Q4 Results: Benchmarking Opendoor (NASDAQ:OPEN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQd2dhTGtvaWttYm00SVVOSjVaSDNEd2Z4SnE1UGhqblMxOERhVFppWE1BRFUxdWJDY1FVZFFNSnljQm4yWTB6S09ERDY5Q0w1M2FmUUFqckFJQzQyMFRlbTJSVVJ2M0tpN0c3QUtiNjVSd3c2dk1CX2VHYmJSZmp4RzRtZE9IeHhWWTJjd2dhcDZYMnJNSWoyY1NiZFh3bWV5X0M0SE1jZXByMGZB?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Cushman & Wakefield (NYSE:CWK) In The Context Of Other Consumer Discretionary - Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQejZkUlJvckROSUlPQjBBUjVid2hyeEtNX3gyZkpRcUJYVDFrcjY2WjVfWC1aRTU4bUl4QVl2N1Frcmx2STd5TmpPQ2d3NXZJc0NQOWRWRjU1elNzVmFpMEJqUFZnRUtLZDNfd214WTdHVEl4c0Y5RDNSam9ZclBFTWlRUE13TFR1OTZmWlUyUVBIRFNGOHd0TVR1bF9sWEd6X20yakRSdw?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: eXp World (NASDAQ:EXPI) Vs The Rest Of The Consumer Discretionary - Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPa2lmZ2ZXU2hYUTYxUDRWOXh6STlZc2dyRXJYaEZDeUJLN21xN3dNRVQ0NnBxeDc2MHBMYkFJUzNlbVExcFBUVmtqVHRQZklUSU5BZGVpUzdfTjQ2YmFJOXI5UEQ2YWhEYXdyaXlhTWQ4TnFBXzJYdm5lODNFR1hwaVgyY0c5MTFPbC1uaGt6Ym5nUjh5T0lxWGotM1U1UQ?oc=5", "source_name": "Market source", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Consumer Discretionary - Real Estate Services Stocks\u2019 Q4 Earnings: Newmark (NASDAQ:NMRK) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPYkxkWFlHWmhoTW5kR1gzS1RlRVZkb201Q1VyTW5wa2JGZk9SVUQ5T2lQWGtqWjlHQnRoV21nM25wMVlyLWxHanpnUEhWdmo2VHhGMTRacE9RdGVRVDBWOWRocGtqMHRjWW80VU5UUE1tYk9qTGVfQnhuX0p2Q295Wlk3UmR3Nm93aVdtbHhWNldSMWU0amc2TmFmc293MEZlcTk0dQ?oc=5", "source_name": "Market source", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Reflecting On Consumer Discretionary - Real Estate Services Stocks\u2019 Q4 Earnings: CBRE (NYSE:CBRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQVk05VHQ4OVdTZGVGWG9kVGc0VWxPa0JfcXkyelczNVRwU19nWGk1UmFrbjFKY2NENEJLMkxDNE9tUl90dHQ5YWxDMGF0U2hlYjFhOHY5eWl4emxpZno0R0xmWjNoX2NxV3JoRkhVNUVFOFBfT3lhckhnUlpNbUM5YmMzVUhZNTlWX0tMaWdkQmFIZnlSLWc?oc=5", "source_name": "Market source", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q3 Earnings Outperformers: JLL (NYSE:JLL) And The Rest Of The Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxPU2pnSHNMWTE2SGYzUE1KcWJpd0xXYm5LOXdudDFkSmtIU1VHamJxa282NEFCUkxhR2JGOHprRzhNZ2h1NlpxSGZESmhiWWFnTy1uRmlfcEtWSjlVUHNidFN3V3o3WHo3aFVNb0dnUlJ1MU4wTGxuTlRXQldGazVDSDZTUnVTanhfWXNaNXRtUzdQZXE4RXpzTkdNNHVGLXNnNVB1YkZmQUlaOEh5YmJxLUFqT09YelJRZDhmOXNzRXNkd2xvbFl6MWU0WkpaZnNoQkdGV0VRb0draU0?oc=5", "source_name": "StockStory", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q3 Earnings Highs And Lows: Opendoor (NASDAQ:OPEN) Vs The Rest Of The Real Estate Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNSlMwd2x0OXRZdS1EMUUwSWN3WE56aEdyckFQWjQ4YnNtWHJ4czZHMmtBb01wdk5XT1Q5TVJ2Wm0xMW1YRDJKY3M5Y2pQVXBOTG5mRTZZQnpOQzJlWjVCYXRnaEVSeExYTkU3QzRUN1RoSFR0dGhLWUZVZ1p2MGFILU5mUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 68, "total_relevant": 55, "sentiment_summary": {"positive": 14, "negative": 6, "neutral": 35, "score": 53, "total": 55, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 12.65, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 10.45, "count": 22}, {"event": "deals", "label": "Deals and strategy", "weight": 3.3, "count": 6}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 2.73, "latest_week": "2026-06-19", "one_week_move": 21.9, "four_week_move": 103.7, "twelve_week_move": 118.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.916994, "market_dynamics_buy_signal": false, "relative_strength": 70.719031, "fair_value_gap": 64.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 48.2075, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+21.9% over one week, +103.7% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 11}, {"label": "Market source", "count": 9}, {"label": "TradingKey", "count": 7}, {"label": "The Manila Times", "count": 3}, {"label": "Quiver Quantitative", "count": 3}, {"label": "GlobeNewswire", "count": 2}, {"label": "Investing.com Canada", "count": 2}, {"label": "The Globe and Mail", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 43}, {"label": "Industry context", "count": 12}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Earnings", "count": 22}, {"label": "Deals and strategy", "count": 6}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "43", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+21.9% over one week, +103.7% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Rafael Holdings Inc (RFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages"}], "updated_at": "2026-06-23T02:19:25.902341+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}